The FTC crackdown comes six months after the regulator challenged drugmakers in a similar fashion.
The U.S. is set to see a surge in obesity drug introductions over the next five years. Here’s a rundown of the potential entrants.
For decades April 20 has been a day to celebrate cannabis culture. But 4/20-related marketing may have become a victim of its own success.
The announcement marks the conclusion of a process that began when Eversana acquired the Salerno-based shop last fall.
With the multiple myeloma drug’s climb from fifth- to second-line therapy, Carvykti uptake is set to expand. Legend Biotech CEO Ying Huang discusses timing of a crucial supply bump.
Man on a mission to boost awareness of neurodegenerative disease enlists iconic buildings to glow blue.
As AI fluency improves in pharma marketing, consultants say drugmakers can realize billions in revenue and cost savings.
Having shared full Phase 3 data for rare-disease agent olezarsen earlier this week, execs have their sights set on a 2024 filing and launch.
Runaway demand — and an all-out attempt to slow it down. What was it like to launch the juggernaut that ignited the obesity treatment dynamic?
Language thought to be ‘predictive’ applied mainly to white people on social media. Is this a red flag for AI-based analysis?
MM+M is proud to announce the fourth annual Pinnacle Awards program, which celebrates the medical marketing industry’s most venerable marketers, strategists and creators.
Get the most out of
Register for free and enjoy unlimited access to: